【结 构 式】 |
【分子编号】54660 【品名】4-hydroxybenzenesulfonyl chloride 【CA登记号】 |
【 分 子 式 】C6H5ClO3S 【 分 子 量 】192.6226 【元素组成】C 37.41% H 2.62% Cl 18.41% O 24.92% S 16.65% |
合成路线1
该中间体在本合成路线中的序号:(VI)In a different method, sodium 4-hydroxybenzenesulfonate (V) was converted to the sulfonyl chloride (VI) upon treatment with thionyl chloride in hot 1,2-dichloroethane. Reaction of acid chloride (VI) with aniline provided sulfonamide (VII). Alkylation of the phenolic hydroxyl group of (VII) with 3-chloro-3-methyl-1-butyne (VIII) in the presence of DBU and CuCl gave the propargyl ether (IX), which was then cyclized to benzopyran (IV) under Claisen rearrangement conditions.
【1】 Manley, P.W. (Novartis AG; Novartis Deutschland GmbH); Benzopyrans and pharmaceutical compsns. containing them. EP 0828733; JP 1999505820; US 5905156; WO 9637490 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 54658 | 2,2-dimethyl-N-phenyl-2H-chromene-6-sulfonamide | C17H17NO3S | 详情 | 详情 | |
(V) | 54659 | sodium 4-hydroxybenzenesulfonate | C6H5NaO4S | 详情 | 详情 | |
(VI) | 54660 | 4-hydroxybenzenesulfonyl chloride | C6H5ClO3S | 详情 | 详情 | |
(VII) | 54661 | 4-hydroxy-N-phenylbenzenesulfonamide | C12H11NO3S | 详情 | 详情 | |
(VIII) | 22416 | 3-chloro-3-methyl-1-butyne | 1111-97-3 | C5H7Cl | 详情 | 详情 |
(IX) | 54662 | 4-[(1,1-dimethyl-2-propynyl)oxy]-N-phenylbenzenesulfonamide | C17H17NO3S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Sulfonylation of methyl 5-bromo-3-methylanthranilate (I) with acid chloride (II) affords sulfonamide (III). Subsequent alkylation of the sulfonamide N of (III) with iodomethane and K2CO3 yields (IV). After protection of the phenolic hydroxyl group of (IV) as the silyl ether (V), benzylic halogenation with N-bromosuccinimide furnishes bromide (VI). Displacement of its benzylic bromide with 1-methylpiperazine (VII) occurs with concomitant desilylation to give (VIII). Mitsunobu coupling of phenol (VIII) with 2-butyn-1-ol (IX) leads to the propargyl ether (X). The methyl ester group of (X) is then hydrolyzed under alkaline conditions to furnish the carboxylic acid (XI).
【1】 Levin, J.I.; Chen, J.M.; Du, M.T.; Nelson, F.C.; Killar, L.M.; Skala, S.; Sung, A.; Jin, G.; Cowling, R.; Barone, D.; March, C.J.; Mohler, K.M.; Black, R.A.; Skotnicki, J.S.; Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group. Bioorg Med Chem Lett 2002, 12, 8, 1199. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 60447 | methyl 2-amino-5-bromo-3-methylbenzoate | C9H10BrNO2 | 详情 | 详情 | |
(II) | 54660 | 4-hydroxybenzenesulfonyl chloride | C6H5ClO3S | 详情 | 详情 | |
(III) | 60448 | methyl 5-bromo-2-{[(4-hydroxyphenyl)sulfonyl]amino}-3-methylbenzoate | C15H14BrNO5S | 详情 | 详情 | |
(IV) | 60449 | methyl 5-bromo-2-[[(4-hydroxyphenyl)sulfonyl](methyl)amino]-3-methylbenzoate | C16H16BrNO5S | 详情 | 详情 | |
(V) | 60450 | methyl 5-bromo-2-[[(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)sulfonyl](methyl)amino]-3-methylbenzoate | C22H30BrNO5SSi | 详情 | 详情 | |
(VI) | 60451 | methyl 5-bromo-3-(bromomethyl)-2-[[(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)sulfonyl](methyl)amino]benzoate | C22H29Br2NO5SSi | 详情 | 详情 | |
(VII) | 10061 | 1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine | 109-01-3 | C5H12N2 | 详情 | 详情 |
(VIII) | 60452 | methyl 5-bromo-2-[[(4-hydroxyphenyl)sulfonyl](methyl)amino]-3-[(4-methyl-1-piperazinyl)methyl]benzoate | C21H26BrN3O5S | 详情 | 详情 | |
(IX) | 42514 | 2-butyn-1-ol | 764-01-2 | C4H6O | 详情 | 详情 |
(X) | 60453 | methyl 5-bromo-2-[{[4-(2-butynyloxy)phenyl]sulfonyl}(methyl)amino]-3-[(4-methyl-1-piperazinyl)methyl]benzoate | C25H30BrN3O5S | 详情 | 详情 | |
(XI) | 60454 | 5-bromo-2-[{[4-(2-butynyloxy)phenyl]sulfonyl}(methyl)amino]-3-[(4-methyl-1-piperazinyl)methyl]benzoic acid | C24H28BrN3O5S | 详情 | 详情 |